• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蒙古的乳腺癌:一个日益重要的卫生政策问题。

Breast cancer in Mongolia: an increasingly important health policy issue.

作者信息

Demchig Delgermaa, Mello-Thoms Claudia, Brennan Patrick C

机构信息

Medical Image Optimization and Perception Group (MIOPeG), Faculty of Health Science, The University of Sydney, Sydney, NSW, Australia.

出版信息

Breast Cancer (Dove Med Press). 2017 Jan 20;9:29-38. doi: 10.2147/BCTT.S125584. eCollection 2017.

DOI:10.2147/BCTT.S125584
PMID:28176935
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5268367/
Abstract

Breast cancer is a leading cause of cancer-related death for women in both developed and developing countries. The incidence and mortality of breast cancer in Mongolia, while low compared with other counties, has been increasing on an annual basis. In addition, in Mongolia, approximately 90% of the patients are diagnosed at a late stage, resulting in high mortality, with the majority of individuals diagnosed with breast cancer dying within 5 years of diagnosis. Breast cancer screening plays an important role in reducing mortality in Western countries and has been adopted by a number of Asian countries; however, no such approach exists in Mongolia. In a country of limited resources, implementation of expensive health strategies such as screening requires effective allocations of resources and the identification of the most effective imaging methods. This requirement relies on recent accurate data; however, at this time, there is a paucity of information around breast cancer in Mongolia. Until data around features of the disease are available, effective strategies to diagnose breast cancer that recognize the economic climate in Mongolia cannot be implemented and the impact of breast cancer is likely to increase.

摘要

在发达国家和发展中国家,乳腺癌都是女性癌症相关死亡的主要原因。蒙古的乳腺癌发病率和死亡率虽然与其他国家相比很低,但一直在逐年上升。此外,在蒙古,约90%的患者在晚期才被诊断出来,导致死亡率很高,大多数被诊断为乳腺癌的人在确诊后5年内死亡。乳腺癌筛查在西方国家降低死亡率方面发挥着重要作用,并且已经被一些亚洲国家采用;然而,蒙古却没有这样的方法。在一个资源有限的国家,实施像筛查这样昂贵的健康策略需要有效地分配资源,并确定最有效的成像方法。这一要求依赖于近期的准确数据;然而,目前蒙古关于乳腺癌的信息匮乏。在获得有关该疾病特征的数据之前,无法实施认识到蒙古经济状况的有效的乳腺癌诊断策略,乳腺癌的影响可能会加剧。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d52e/5268367/d91d3f067fd6/bctt-9-029Fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d52e/5268367/d0ec2d60fa90/bctt-9-029Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d52e/5268367/992b5fd3f3a6/bctt-9-029Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d52e/5268367/e71e25726ab5/bctt-9-029Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d52e/5268367/5df559164e79/bctt-9-029Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d52e/5268367/9420d616464e/bctt-9-029Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d52e/5268367/d91d3f067fd6/bctt-9-029Fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d52e/5268367/d0ec2d60fa90/bctt-9-029Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d52e/5268367/992b5fd3f3a6/bctt-9-029Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d52e/5268367/e71e25726ab5/bctt-9-029Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d52e/5268367/5df559164e79/bctt-9-029Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d52e/5268367/9420d616464e/bctt-9-029Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d52e/5268367/d91d3f067fd6/bctt-9-029Fig6.jpg

相似文献

1
Breast cancer in Mongolia: an increasingly important health policy issue.蒙古的乳腺癌:一个日益重要的卫生政策问题。
Breast Cancer (Dove Med Press). 2017 Jan 20;9:29-38. doi: 10.2147/BCTT.S125584. eCollection 2017.
2
Responding to the challenges of breast cancer in egypt and other arab countries.应对埃及及其他阿拉伯国家乳腺癌带来的挑战。
J Egypt Natl Canc Inst. 2008 Dec;20(4):309-12.
3
Mammography screening: A major issue in medicine.乳腺 X 光筛查:医学中的一个重大问题。
Eur J Cancer. 2018 Feb;90:34-62. doi: 10.1016/j.ejca.2017.11.002. Epub 2017 Dec 20.
4
5
Tuberculosis结核病
6
Spectrum of breast cancer in Asian women.亚洲女性乳腺癌的谱系
World J Surg. 2007 May;31(5):1031-40. doi: 10.1007/s00268-005-0585-9.
7
Exploring Knowledge, Attitudes, and Practices Related to Breast and Cervical Cancers in Mongolia: A National Population-Based Survey.蒙古国乳腺癌和宫颈癌相关知识、态度及行为的探索:一项基于全国人口的调查
Oncologist. 2015 Nov;20(11):1266-73. doi: 10.1634/theoncologist.2015-0119. Epub 2015 Sep 28.
8
Colon Cancer Screening - Is It Time Yet?结肠癌筛查——是时候了吗?
J Coll Physicians Surg Pak. 2017 Jun;27(6):327-328.
9
Cancer incidence and mortality in Mongolia - National Registry Data.蒙古的癌症发病率和死亡率——国家登记数据
Asian Pac J Cancer Prev. 2010;11(6):1509-14.
10
Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.预防性卵巢切除术:降低美国上皮性卵巢癌死亡率。一场持续的争论。
Oncologist. 1996;1(5):326-330.

引用本文的文献

1
miR-30d-5p inhibits proliferation, invasion and migration of breast cancer cells by targeting SERPINE1 and promoting fatty acid β-oxidation.miR-30d-5p通过靶向丝氨酸蛋白酶抑制剂1(SERPINE1)并促进脂肪酸β-氧化来抑制乳腺癌细胞的增殖、侵袭和迁移。
Aging (Albany NY). 2024 Feb 22;16(7):5856-5865. doi: 10.18632/aging.205587.
2
A longitudinal association between the traditional Japanese diet score and incidence and mortality of breast cancer-an ecological study.传统日式饮食评分与乳腺癌发病率和死亡率的纵向关联:一项生态学研究。
Eur J Clin Nutr. 2021 Jun;75(6):929-936. doi: 10.1038/s41430-020-00847-5. Epub 2021 Jan 29.
3

本文引用的文献

1
Cancer incidence and cancer control in Mongolia: Results from the National Cancer Registry 2008-12.蒙古国的癌症发病率与癌症防治:2008 - 2012年国家癌症登记处的结果
Int J Cancer. 2017 Jan 15;140(2):302-309. doi: 10.1002/ijc.30463. Epub 2016 Oct 24.
2
Mammography screening in less developed countries.欠发达国家的乳腺钼靶筛查。
Springerplus. 2015 Oct 15;4:615. doi: 10.1186/s40064-015-1394-8. eCollection 2015.
3
Benefits and Harms of Breast Cancer Screening: A Systematic Review.乳腺癌筛查的获益与危害:系统评价。
A Combination of an Antimitotic and a Bromodomain 4 Inhibitor Synergistically Inhibits the Metastatic MDA-MB-231 Breast Cancer Cell Line.
一种抗有丝分裂药物与溴结构域蛋白 4 抑制剂联合使用可协同抑制转移性 MDA-MB-231 乳腺癌细胞系。
Biomed Res Int. 2019 Dec 11;2019:1850462. doi: 10.1155/2019/1850462. eCollection 2019.
JAMA. 2015 Oct 20;314(15):1615-34. doi: 10.1001/jama.2015.13183.
4
National Breast Cancer Screening Programme, Singapore: evaluation of participation and performance indicators.新加坡国家乳腺癌筛查计划:参与度和绩效指标评估
J Med Screen. 2015 Dec;22(4):194-200. doi: 10.1177/0969141315589644. Epub 2015 Jun 16.
5
Global cancer statistics, 2012.全球癌症统计数据,2012 年。
CA Cancer J Clin. 2015 Mar;65(2):87-108. doi: 10.3322/caac.21262. Epub 2015 Feb 4.
6
Performance of digital screening mammography among older women in the United States.美国老年女性数字乳腺筛查的效果
Cancer. 2015 May 1;121(9):1379-86. doi: 10.1002/cncr.29214. Epub 2014 Dec 23.
7
Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2).1995 - 2009年全球癌症生存情况监测:对来自67个国家279个基于人群的登记处的25,676,887例患者的个体数据进行分析(CONCORD - 2)
Lancet. 2015 Mar 14;385(9972):977-1010. doi: 10.1016/S0140-6736(14)62038-9. Epub 2014 Nov 26.
8
Breast cancer in low and middle income countries (LMICs): a shifting tide in global health.低收入和中等收入国家(LMICs)的乳腺癌:全球健康领域的转变趋势
Breast J. 2015 Jan-Feb;21(1):111-8. doi: 10.1111/tbj.12357. Epub 2014 Nov 29.
9
Improving outcomes in breast cancer for low and middle income countries.改善低收入和中等收入国家乳腺癌的治疗效果。
World J Surg. 2015 Mar;39(3):686-92. doi: 10.1007/s00268-014-2859-6.
10
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.全球癌症发病与死亡:GLOBOCAN 2012 数据源、方法与主要模式。
Int J Cancer. 2015 Mar 1;136(5):E359-86. doi: 10.1002/ijc.29210. Epub 2014 Oct 9.